Oral Kaposi Sarcoma in two patients living with HIV despite sustained viral suppression: New clues

• Published in: Journal of clinical and experimental dentistry 2022-05, Vol.14 (5), p.e453-e456
• Main Authors: Messeca, Clement, Balanger, Matthieu, Geoffroy, Florent, Duval, Xavier, Samimi, Mahtab, Millot, Sarah
• Format: Article
• Language: English
• Subjects: Case Report
• ISSN: 1989-5488; 1989-5488
• DOI: 10.4317/jced.59610

Kaposi sarcoma (KS) etiologically linked to Kaposi sarcoma-associated herpesvirus (KSHV) is the most common HIV associated cancer despite the generalization of antiretroviral therapy. Head, neck, and especially oral cavity are common and specific sites for lesions. Those oral lesions contain a high viral load of KSHV virus and are one of the signs of disease severity. The development of KS in HIV-infected patients is classically described in case of low CD4 count, but recently reported cases revealed oral KS despite a robust CD4 count, such observations being possibly linked to interactions between periodontal germs and the oncogenic KSHV virus. We present two cases of KS location on the oral mucosa in HIV patients with gingival inflammation despite efficient antiretroviral treatment and immune restoration. Those cases suggest that the diagnosis of oral KS lesions should be considered by oral surgeons, dermatologists, and infectious specialists, when managing any suspicious lesion in an HIV patient, even with undetectable HIV viral loads, or in a seronegative patient with unprotected sexual activity. Kaposi Sarcoma, KSHV, HIV infection, CD4 count, oral lesion, oral cancer, periodontal pathogens.